Cleared Traditional

K030730 - FREE TESTOSTERONE ENZYMEIMMUNOASSAY (EIA) KIT

K030730 is an FDA 510(k) clearance for FREE TESTOSTERONE ENZYMEIMMUNOASSAY (EI..., manufactured by Diagnostics Biochem Canada, Inc.. The device is a Class 1 Chemistry device with product code CDZ cleared through the Traditional 510(k) pathway after a 161-day FDA review.

K030730 · Diagnostics Biochem Canada, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2003
Decision
161d
Days
Class 1
Risk

K030730 is an FDA 510(k) clearance for the FREE TESTOSTERONE ENZYMEIMMUNOASSAY (EIA) KIT. Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Diagnostics Biochem Canada, Inc. (London, Ontario, CA). The FDA issued a Cleared decision on August 18, 2003 after a review of 161 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1680 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diagnostics Biochem Canada, Inc. devices

FDA 510(k) Submission Details - K030730

510(k) Number K030730 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 2003
Decision Date August 18, 2003
Days to Decision 161 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
73d slower than avg
Panel avg: 88d · This submission: 161d
Pathway characteristics
Predicate-based equivalence.

CDZ Device Classification - Class 1, General Controls

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 70
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K030730.
DRG SLV TESTOSTERONE ELISA TEST
K052649 · Drg Intl., Inc. · Jan 2006
ABBOTT AXSYM TESTOSTERONE MICROPARTICLE ENZYME IMMUNOASSAY (MEIA)
K041866 · Axis-Shield Diagnostics, Ltd. · Sep 2004
IMMULITE/IMMULITE 1000 TOTAL TESTOSTERONE AND IMMULITE 2000 TOTAL TESTOSTERONE
K032881 · Diagnostic Products Corp. · Oct 2003
ELECSYS SHBG IMMUNOASSAY
K031717 · Roche Diagnostics Corp. · Aug 2003
ST AIA-PACK TESTOSTERONE ASSAY
K023091 · Tosoh Medics, Inc. · Dec 2002
VIDAS TESTOSTERONE (TES), MODEL 30 418
K021326 · bioMerieux, Inc. · Jul 2002